(PharmaNewsWire.Com, July 14, 2020 ) The healthcare contract management software market is projected to reach USD 1,763 million by 2024 from USD 755 million in 2019, at a CAGR of 18.5% during the forecast period. Key players in this market include Determine Inc. (US), CobbleStone Software (US), Concord (US), Contract Logix LLC (US), Icertis (US), Apttus Corporation (US), Optum Inc. (US), nThrive Inc. (US), Experian Plc. (Ireland), Coupa Software Inc. (US), and ScienceSoft (US).
Key players are focusing on increasing their presence in this high-growth market through both organic as well as inorganic growth strategies, such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions. Due to the intense competition in this market, major market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players with desired manufacturing capabilities or geographic presence.
Icertis (US) was the leading player in the healthcare contract management software market and accounted for the largest share in 2018. The company offers advanced product offerings, which include cloud-based contract lifecycle management software. Icertis’s position in the market can be attributed to its active R&D activities and wide distribution footprint across the world.
To garner a large share of the healthcare contract management software market, the company continuously focuses on geographic expansion. For instance, in October 2018, the company opened two new offices in Sydney and Singapore to meet the rising market demand. Similarly, in June 2018, Icertis opened a new support center in Sofia, Bulgaria, to strengthen their business growth in the European market.
Apttus (US) held the second-largest share of the healthcare contract management software market. Its position in the market can be attributed to its strong product portfolio and strong distribution channel across the world. To maintain its position in the market, the company focuses on expanding its product portfolio through strategies such as product launches and agreements. For instance, in September 2018, the company entered into an agreement with Thoma Bravo, LLC. (US), a private equity investment firm. Under the agreement, Thoma Bravo will acquire a majority interest in Apttus. Through this agreement, Apttus enhanced its company’s growth and was also able to take advantage of huge market opportunities.
“North America to hold the largest regional market share in 2019.”
North America is expected to account for the largest share of the healthcare contract management software market in 2019, followed by Europe. The large share of North America can be attributed to the favorable regulations (such as the Meaningful Use and Health Insurance Portability & Accountability Act) combined with the large number of hospitals and the presence of a number of private insurance players. In addition, well-established government payers are further supporting the growth of this market.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: